PUMA BIOTECHNOLOGY, INC.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2012 | — | $42.6M | $50.2M |
| Jun 2012 | — | $28.0M | $41.0M |
| Sep 2012 | — | $9.0M | $33.3M |
| Dec 2012 | — | $128.9M | $137.4M |
| Mar 2013 | — | $118.3M | $91.6M |
| Jun 2013 | — | $107.0M | $60.9M |
| Sep 2013 | — | $94.8M | $51.3M |
| Dec 2013 | — | $84.0M | $43.0M |
| Mar 2014 | — | $198.8M | $163.4M |
| Jun 2014 | — | $167.0M | $55.4M |
| Sep 2014 | — | $141.6M | $28.3M |
| Dec 2014 | — | $117.0M | $38.5M |
| Mar 2015 | — | $304.3M | $155.5M |
| Jun 2015 | — | $274.8M | $59.8M |
| Sep 2015 | — | $244.8M | $23.6M |
| Dec 2015 | — | $206.0M | $31.6M |
| Mar 2016 | — | $164.9M | $78.2M |
| Jun 2016 | — | $127.1M | $57.8M |
| Sep 2016 | — | $91.1M | $52.5M |
| Dec 2016 | — | $209.8M | $194.5M |